Gaetan C.
- Country
- Belgium
- Department
- Oncology
Research Overview
- A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or without Platinum Chemotherapy, in Subjects with No Prior Therapy for Advanced or Metastatic PD-L1 TPS<50% Non-squamous Non-small Cell Lung Cancer without Actionable Genomic Alterations (TROPION-Lung07)
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Patients With Previously Treated TROP2-Positive Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Phase 2 Open‑Label Multicohort Study of Rinatabart Sesutecan Monotherapy in Patients with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 217 of 446 partner sites.
Specializations
Advanced Lung Cancer Research
This investigator specializes in studying novel treatments for non-squamous non-small cell lung cancer (NSCLC), with particular focus on advanced and metastatic cases.
- c-Met overexpressing EGFR wildtype conditions
- PD-L1 expressing tumors
- TROP2 biomarker positive cases
The research encompasses both locally-advanced and metastatic disease states requiring systemic therapy.
Immunotherapy Approaches
Expertise in evaluating innovative immunotherapy combinations for lung cancer treatment, including investigation of novel antibody-drug conjugates and immune checkpoint inhibitors.
- Combination immunotherapy protocols
- Targeted antibody treatments
- Checkpoint inhibitor therapy
Areas of focus include assessment of treatment efficacy in specific biomarker-defined patient populations.
Treatment Strategies
Investigates therapeutic approaches for various stages of lung cancer, from locally advanced to metastatic disease.
- First-line treatment protocols
- Post-chemotherapy interventions
- Maintenance therapy strategies
The research evaluates both single-agent and combination treatment approaches across different disease stages.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.